Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Hormonal shifts during substantial weight loss could play a role in people with a genetic predisposition
Tirzepatide (Monjaro) is the newest medication designed to address type 2 diabetes and obesity by targeting multiple hormones involved in regulating blood sugar levels and appetite, potentially offering a more comprehensive approach to managing these conditions
BED and BED of low frequency and/or limited duration Binge-eating episodes are the main feature of BED
This can be particularly helpful in addressing estrogen dominance
US$ 22.28
US$ 27.53
US$ 29.19
US$ 24.25
